4//SEC Filing
Wade M. Andrew 4
Accession 0001209191-20-011855
CIK 0001323885other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:14 AM ET
Size
20.6 KB
Accession
0001209191-20-011855
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2020-02-21$6.73/sh+15,000$100,950→ 160,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 0 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (15,000 underlying) - Sale
Common Stock
2020-02-21$39.45/sh−15,000$591,750→ 145,120 total - Sale
Common Stock
2020-02-21$39.45/sh−15,000$591,750→ 145,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 60,000 totalExercise: $6.73From: 2013-12-27Exp: 2022-12-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-02-21$6.73/sh+15,000$100,950→ 160,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-02-21−15,000→ 45,000 totalExercise: $6.73From: 2013-12-27Exp: 2022-12-27→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-02-21$6.27/sh+15,000$94,050→ 160,120 total - Sale
Common Stock
2020-02-21$39.46/sh−15,000$591,900→ 145,120 total
Footnotes (5)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $38.94 to $40.60 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
- [F5]These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001560591
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:14 AM ET
- Size
- 20.6 KB